Chemotherapy-related cognitive impairment in older patients with cancer.
Kah Poh Loh, Michelle C Janelsins, Supriya G Mohile...
https://pubmed.ncbi.nlm.nih.gov/27197918/Actively Recruiting
Led by Karolinska Institutet · Updated on 2026-08-11
130
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are investigating the occurrence of Post Operative Delirium POD following surgery for stomach or esophageal cancer. This observational study aims to understand how often POD occurs and explore its connections with factors such as preoperative depression, frailty, quality of life, malnutrition, and muscle loss sarcopenia. Participants who experience POD will have the opportunity to share their experiences through interviews. Participants will undergo cognitive assessments using the 4AT Test at several points before chemotherapy if applicable, upon hospital admission for surgery, on days 1, 3, and 7 after surgery, and again 4 to 8 weeks post-surgery during follow-up. Various tools will be used to evaluate related health aspects, including questionnaires for quality of life, scales for frailty and depression, assessments for malnutrition, and CT scans to measure sarcopenia. Throughout the study, participants will be monitored from enrollment until about six months after surgery. Assessments include tracking the incidence of POD, measuring preoperative depression and frailty, evaluating quality of life changes, and checking nutritional status and muscle condition. Those who develop POD will be invited for a qualitative interview to capture their personal experiences. The study is sponsored by Karolinska Institutet and aims to deepen understanding of cognitive impacts related to cancer surgery.
CONDITIONS
Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer
M
Marcus Nömm, PhD-student
M
Maria Lampi, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Karolinska Institutet
Lead Sponsor
Region Stockholm
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - From enrollment until about 6 months after surgery
Participants undergo cognitive tests before chemotherapy if applicable, at hospital admission for surgery, on postoperative days 1, 3, and 7, and at follow-up 4 to 8 weeks after surgery. Questionnaires and evaluations for depression, frailty, nutrition, and muscle loss are also completed.
Multiple visits including pre-surgery, hospital stay, and follow-up
Duration - Single visit at routine follow-up after surgery
Participants who develop postoperative delirium are invited to participate in an interview to share their experiences during routine follow-up after surgery.
1 visit (in-person or remote as arranged)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Kah Poh Loh, Michelle C Janelsins, Supriya G Mohile...
https://pubmed.ncbi.nlm.nih.gov/27197918/Christopher G Hughes, Christina S Boncyk, Deborah J Culley...
https://pubmed.ncbi.nlm.nih.gov/32022748/Zoë Tieges, Alasdair M J Maclullich, Atul Anand...
https://pubmed.ncbi.nlm.nih.gov/33951145/Jing Liu, Jianli Li, Jing Wang...
https://pubmed.ncbi.nlm.nih.gov/37260053/Karolinska Institutet
Lead Sponsor
Region Stockholm
Collaborating Sponsor